Augliptin Hydrochloride

盐酸澳格列汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAugliptin Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Sun-Sail Pharmaceutical Science & Technology Co LtdNanjing Changao Pharmaceutical Science And Technologyco Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Changao Pharmaceutical Science And Technologyco LtdShanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A